4//SEC Filing
Burrell Terry-Ann 4
Accession 0001209191-23-042305
CIK 0001601830other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 6:52 PM ET
Size
13.1 KB
Accession
0001209191-23-042305
Insider Transaction Report
Form 4
Burrell Terry-Ann
Director
Transactions
- Sale
Class A Common Stock
2023-07-12$11.25/sh−24,302$273,400→ 147,545 total - Sale
Class A Common Stock
2023-07-12$14.08/sh−3,157$44,457→ 63,122 total - Sale
Class A Common Stock
2023-07-12$12.15/sh−78,071$948,289→ 69,474 total - Sale
Class A Common Stock
2023-07-12$13.18/sh−3,195$42,124→ 66,279 total - Sale
Class A Common Stock
2023-07-13$12.59/sh−8,275$104,143→ 54,847 total
Footnotes (6)
- [F1]Sales are pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 18, 2022.
- [F2]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $10.60 to $11.59 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F3]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $11.60 to $12.54 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F4]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.76 to $13.72 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F5]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $13.81 to $14.56 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
- [F6]The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $12.105 to $12.98 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
Documents
Issuer
RECURSION PHARMACEUTICALS, INC.
CIK 0001601830
Entity typeother
Related Parties
1- filerCIK 0001786484
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 6:52 PM ET
- Size
- 13.1 KB